Correction to: Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real‑world, multi‑center, matched analysis (Annals of Hematology, (2022), 101, 9, (2001-2010), 10.1007/s00277-022-04895-8)

Shai Shimony, Jonathan Canaani, Eitan Kugler, Boaz Nachmias, Ron Ram, Israel Henig, Avraham Frisch, Chezi Ganzel, Vladimir Vainstein, Yakir Moshe, Shlomzion Aumann, Moshe Yeshurun, Yishai Ofran, Pia Raanani, Ofir wolach

Research output: Contribution to journalComment/debate

Abstract

In the published paper, the author Israel Henig who also contributed to the manuscript was accidentally dropped from the co-author list. The original article has been corrected.

Original languageEnglish
Pages (from-to)2011
Number of pages1
JournalAnnals of Hematology
Volume101
Issue number9
DOIs
StatePublished - Sep 2022

Fingerprint

Dive into the research topics of 'Correction to: Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real‑world, multi‑center, matched analysis (Annals of Hematology, (2022), 101, 9, (2001-2010), 10.1007/s00277-022-04895-8)'. Together they form a unique fingerprint.

Cite this